ArthroCare to Announce First Quarter Financial Results April 18.

Business Editors/Health & Medical Writers

SUNNYVALE, Calif.--(BW HealthWire)--April 12, 2002

ArthroCare Corporation (Nasdaq:ARTC) today announced that the company will release financial results for the first quarter of fiscal 2002, ended March 30, 2002, on Thursday, April

A live webcast of the conference call will be available online at www.ccbn.com. A copy of the press release and a link to the webcast will be available on the company's website www.arthrocare.com. The webcast will remain available through May 3, 2002. A replay of the conference call will also be available by phone at 800-633-8284, reservation number 20514136 through May 3.

ABOUT ARTHROCARE

ArthroCare Corp. (www.arthrocare.com), headquartered in Sunnyvale, Calif., is a multi-business medical device company that develops, manufactures and markets minimally invasive surgical products based on its patented and pioneering Coblation technology. Coblation technology uses low-temperature radio-frequency energy to gently dissolve rather than burn or cut soft tissue, which minimizes damage to surrounding tissue thereby potentially decreasing patient pain and recovery time. ArthroCare is capitalizing on a $2.8 billion market opportunity, targeting established surgical procedures where its Coblation-based devices can quickly and effectively replace traditional electrosurgical or laser surgery tools. Coblation technology currently is used by surgeons for arthroscopic, spine/neurologic, ear, nose and throat, cosmetic, urologic, gynecologic and laparoscopic/general surgical procedures. ArthroCare's Coblation-based devices have been used in more than 1.5 million surgical procedures worldwide.